By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ardelyx Inc. 

34175 Ardenwood Boulevard
Suite 100
Fremont  California  94555  U.S.A.
Phone: 510-745-1700 Fax: n/a


SEARCH JOBS








Company News
Ardelyx Inc. (ARDX) Presents Positive Results From Its Phase 2b Clinical Trial Evaluating Tenapanor In IBS-C Patients At Digestive Disease Week 2015 5/20/2015 6:16:18 AM
Ardelyx Inc. (ARDX) Reports First Quarter 2015 Financial Results 5/13/2015 6:56:19 AM
Ardelyx Inc. (ARDX) Reports Results From Phase 2a Clinical Trial Evaluating Tenapanor In Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus And Albuminuria 5/6/2015 6:27:37 AM
Ardelyx Inc. (ARDX) Appoints Dr. Annalisa Jenkins To Its Board Of Directors 4/20/2015 12:16:09 PM
Ardelyx Inc. (ARDX) To Present At The 22nd Annual Future Leaders In The Biotech Industry Conference 3/13/2015 9:02:27 AM
Ardelyx Inc. (ARDX) Reports Fourth Quarter and Full Year 2014 Financial Results 2/26/2015 7:35:14 AM
Ardelyx Inc. (ARDX) To Report Fourth Quarter And Full Year 2014 Financial Results On February 25th, 2015 2/18/2015 12:57:28 PM
Ardelyx Inc. (ARDX) To Present At The 2015 Leerink Global Healthcare Conference 2/9/2015 11:53:09 AM
Ardelyx Inc. (ARDX) Reports Results from Phase 2b Clinical Trial Evaluating Tenapanor In Treating Hyperphosphatemia In Chronic Kidney Disease Patients On Hemodialysis 2/2/2015 9:23:31 AM
Ardelyx Inc. (ARDX) Appoints Jeremy S. Caldwell, Ph.D., As Executive Vice President And Chief Scientific Officer 12/1/2014 4:02:58 PM
123
//-->